FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

34733511000001104: Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105008501000001116 Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105008601000001117 Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register Exempt Safe Custody) true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Is a Tramadol 100mg modified-release tablets 60 tablet true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Has AMP Brimisol PR 100mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Has specific active ingredient Tramadol hydrochloride true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Brimisol PR 100mg tablets (Bristol Laboratories Ltd) 60 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start